Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Medula Majority
Nabila Rayhan Yasmin
Unknown Affiliation
Education Health Professions Medicine & Pharmacology Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Potensi Astragalus Sebagai Terapi Adjuvan Pada Pasien Glomerulonefritis Alfina Indah Nabila; Nabila Rayhan Yasmin; Rani Himayani; Ramadhan Triyandi
Medula Vol 13 No 5 (2023): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v13i5.783

Abstract

Glomerulonephritis is a medical term used to describe a condition that involves some kidney damages. Glomerulonephritis is an abnormality of the kidney that may lead to end-stage renal disease (ESRD). The current glomerulonephritis therapy is considered not fully effective due to the possibility of additional morbidity and complications that may occur. The use of Astragalus as adjuvant therapy can inhibit the progression of glomerulonephritis. The journals, that was reviewed, obtained from the Google Scholar, Sciencedirect, PubMed, and Springer with a publication year range of 2009-2023. The journals were selected to obtain valid and reliable journals, then do a literature review and article writing. Astragalus membranaceus has a bioactive content that can act as an immunomodulator, antiinflamation, and renoprotector. Astragalus is able to improve kidney function through IL-6 secretion and improve kidney interstitial fibrosis. Administration of Astragalus in combination with conventional therapy can reduce serum creatinine and proteinuria. Astragalus has potential as adjuvant therapy in glomerulonephritis patients.
Kurkumin Aerosol dengan Media Nasal Spray sebagai Terapi Preventif dan Kuratif Penderita Alzheimer Nabila Rayhan Yasmin; Rr Astri Nur Azizah Utama; Mukhlis Imanto
MAJORITY Vol 10 No 1 (2021): MAJORITY
Publisher : Majority

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Alzheimer is a neurodegenerative disease which is the third leading cause of death for elderly in the world. Until now, no effective therapeutic management has been found for Alzheimer's patient. Curcumin is known to have powerful antioxidant, anti-inflammatory, and anti-amylogenic properties so it has the potential to prevent and treat Alzheimer's disease. A review of the journals obtained using search engines such as Google Scholar, Proquest, Sciencedirect, NCBI, PubMed, and Springer were conducted with a publication year spanning 2011-2021. The journals obtained are then selected to obtain valid and reliable journals. Then a literature review and article writing are conducted. Curcumin has the ability to inhibit the formation and spread of free radicals, affect the work of macrophages in cleaning β-amyloid plaque, reduce the production of proinflammatory cytokines, and mainly inhibit the accumulation and aggregation of β-amyloid. Curcumin needs to be distributed appropriately in order to have its maximum therapeutic effect. Aerosol-based delivery of curcumin has been shown to deliver most of the therapeutic compounds to the brain without causing systemic toxicity or drug degradation in the liver. The use of nasal spray media can support the delivery of aerosol curcumin via the nasal route because it can transport drugs through the brain more efficiently. Aerosol curcumin with nasal spray device has the potential as a preventive and curative therapy for Alzheimer's disease
Co-Authors Alfina Indah Nabila Mukhlis Imanto Ramadhan Triyandi Rani Himayani Rr Astri Nur Azizah Utama